BioVie Inc.
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-22.1M | $-17.5M | $-32.1M | $-50.3M | $-26.1M | $-130.2M | $-16.7M | $-2.4M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $178.3K | $229.4K | $229.4K | $229.4K | $229.4K | $229.4K | $229.4K | $229.4K |
| Stock-Based Compensation | $2.3M | $1.2M | $2.8M | $4.2M | $5.8M | $3.0M | $24.8K | $64.9K |
| Net Cash from Operating Activities | $-19.0M | $-19.0M | $-27.9M | $-40.3M | $-19.0M | $-10.5M | $-1.6M | $-2.5M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $14.5M | $-14.3M | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $10.5M | $12.7M | $17.8M | $55.4M | $33.1M | $14.9M | $1.3M | $2.8M |
| Net Change in Cash | — | — | — | — | — | $4.5M | $-302.7K | $294.1K |
| Free Cash Flow | — | — | — | — | — | — | — | — |